[Congressional Record Volume 167, Number 90 (Monday, May 24, 2021)]
[Senate]
[Page S3353]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1937. Mr. RUBIO submitted an amendment intended to be proposed to 
amendment SA 1502 proposed by Mr. Schumer to the bill S. 1260, to 
establish a new Directorate for Technology and Innovation in the 
National Science Foundation, to establish a regional technology hub 
program, to require a strategy and report on economic security, 
science, research, innovation, manufacturing, and job creation, to 
establish a critical supply chain resiliency program, and for other 
purposes; which was ordered to lie on the table; as follows:

        At the appropriate place in subtitle A of title I of 
     division F, insert the following:

     SEC. 61__. REQUIREMENT OF CERTIFICATION OF LABORATORIES.

       Section 353 of the Public Health Service Act (42 U.S.C. 
     263a) is amended--
       (1) by redesignating subsection (q) as subsection (r); and
       (2) by inserting after subsection (p) the following:
       ``(q) Ties to the People's Republic of China.--
       ``(1) In general.--Each certificate issued by the Secretary 
     under this section shall state whether--
       ``(A) the laboratory;
       ``(B) the company that owns or manages the laboratory; or
       ``(C) any subcontractors or subsidiaries of such a 
     laboratory or company,
     is an entity described in paragraph (2).
       ``(2) Entity described.--An entity described in this 
     paragraph is an entity--
       ``(A)(i) that is engaged in the biological, 
     microbiological, serological, chemical, immuno-hematological, 
     hematological, biophysical, cytological, pathological, or 
     other examination of materials derived from the human body 
     for the purpose of providing information for the diagnosis, 
     prevention, or treatment of any disease or impairment of, or 
     the assessment of the health of, people of the United States; 
     or
       ``(ii) that handles or has access to any data related to 
     people of the United States that is derived from any activity 
     described in clause (i); and
       ``(B)(i) over which control is exercised or exercisable by 
     the Government of the People's Republic of China, a national 
     of the People's Republic of China, or an entity organized 
     under the laws of the People's Republic of China; or
       ``(ii) in which the Government of the People's Republic of 
     China has a substantial interest.''.
                                 ______